Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.5M Buy
5,243
+63
+1% +$109K 3.4% 7
2026
Q2
$10.3M Sell
5,180
-1,373
-21% -$2.19M 3.79% 4
2026
Q1
$8.65M Sell
6,553
-1,941
-23% -$2.66M 3.22% 8
2025
Q4
$9.09M Sell
8,494
-65
-0.8% -$67.8K 3.42% 3
2025
Q3
$8.29M Sell
8,559
-92
-1% -$72.3K 3.21% 4
2025
Q2
$6.93M Buy
8,651
+6,050
+233% +$4.34M 2.72% 10
2025
Q1
$1.72M Buy
2,601
+304
+13% +$221K 2.06% 25
2024
Q4
$1.59M Buy
+2,297
New +$1.65M 1.89% 30

Other funds holding ASML

Martin Capital Partners's ASML Position: Q3 2026 in Review

Martin Capital Partners increased its ASML (ASML) stake by 1.2% in Q3 2026, buying an estimated $109K and bringing the position to 5,243 shares worth $9.5M. The position accounts for 3.4% of the portfolio, ranked #7.

Martin Capital Partners first reported a position in ASML in Q4 2024 and has held it in 8 quarters since. The position peaked at $10.3M in Q2 2026. 277 funds tracked by Wall St. Rank hold ASML as of Q3 2026.

  • Martin Capital Partners held 5,243 shares of ASML worth $9.5M as of Q3 2026.
  • Martin Capital Partners bought 63 ASML shares in Q3 2026, an estimated $109K.
  • ASML made up 3.4% of Martin Capital Partners's portfolio in Q3 2026, its #7 holding.
  • Martin Capital Partners first reported a position in ASML in Q4 2024 and has held it in 8 quarters since.
  • Martin Capital Partners's ASML position peaked at $10.3M in Q2 2026.
  • 277 funds tracked by Wall St. Rank held ASML as of Q3 2026.

Based on Martin Capital Partners's 13F filing for Q3 2026, filed 7 Oct 2026.